Highest-materiality recent filing
Macerich issues $775M of 2.25% exchangeable notes due 2031; net proceeds ~$757M
$775M aggregate 2.25% exchangeable senior notes due 2031 issued, incl. $100M option exercise; guaranteed by Macerich on senior unsecured basis.
Macerich files new shelf registration, adds Morgan Stanley and Scotia as ATM agents
Filed new automatic shelf S-3 to replace expired registration; four prospectus supplements continue existing offerings.
Macerich Q2 net loss narrows to $27.1M; FFO as adjusted $0.35; acquires Annapolis Mall for $260M
Net loss attributable to company $27.1M ($0.10 diluted) vs $40.9M loss in Q2 2025; FFO as adjusted $100.4M ($0.35) vs $88.7M ($0.34).
Macerich closes additional 2.1M share forward sale at $23.12 per share
Underwriters exercised option for 2.1M shares at $23.12325/share; closed June 26.
Macerich closes 14M share forward sale at $23.12; proceeds for acquisitions
Forward sale of 14M shares at $23.12325 via Goldman, Deutsche Bank, JPMorgan, Morgan Stanley.
Macerich annual meeting elects eight directors; say-on-pay passes, KPMG ratified
All eight incumbent directors re-elected with strong support; Marianne Lowenthal received 214.8M for (lowest) vs 14.2M against.
Macerich posts investor presentation with Path Forward Plan update; no specifics in filing
Investor presentation made available on Macerich's website on June 1, 2026.
Macerich closes $527M common stock offering; proceeds to repay Annapolis Mall debt
Issued 25.08M shares (including full underwriter option) at $21.00 per share; gross proceeds ~$527M.
Macerich Q1 net loss narrows to $36.4M; FFO as adjusted flat at $0.34/share
Net loss of $36.4M ($0.14 diluted) vs $50.1M loss ($0.20) in Q1 2025.
Business update presentation made available on investor relations website on March 2, 2026.
Macerich closes $900M revolving credit facility, up from $650M, maturing 2029
Aggregate $900M revolver, up from $650M; matures March 1, 2029, with option to extend to 2030.
Macerich Q4 net loss narrows to $18.8M; FFO per share $0.48; record leasing
Q4 net loss $18.8M vs $211.2M loss in Q4 2024; FFO ex-items $128.9M ($0.48) vs $116.7M ($0.47).
Macerich provides business update at Nareit REITWorld; no new financial data in filing
Presentation furnished under Item 7.01 but contains only title slide and legal disclaimer.
Macerich reports Q3 2025 results; details in exhibit not reproduced
Earnings data for three and nine months ended September 30, 2025 furnished as Exhibit 99.1.
Macerich sells Lakewood Center ($332.1M) and Valley Mall ($22.1M) in August 2025
Lakewood Center sold for $332.1M; buyer assumed $317.1M loan maturing June 2026.
Macerich Q2 net loss $40.9M; FFO adj $0.33; acquires Crabtree Mall for $290M
Net loss attributable to company $40.9M ($0.16 diluted) vs net income $252.0M prior year due to Chandler Fashion Center gain.
Macerich acquires Crabtree Mall in Raleigh, NC for $290M; initial yield ~11%
Acquisition of 1.3M sq ft Class A mall in Raleigh, NC for $290M funded with cash on hand and $100M revolver.
Macerich annual meeting results: all director nominees elected, say-on-pay approved, KPMG ratified
Eight directors elected with votes ranging from 215.5M (Diana M. Laing) to 220.0M (Jackson Hsieh).
Investor presentation made available on May 29, 2025, on the company's IR website.
Macerich Q1 net loss narrows to $0.20/share; same-center NOI up 0.9%
Net loss of $50.1M ($0.20/share-diluted) vs loss of $126.7M ($0.59) in Q1 2024.
Director Eric K. Brandt not standing for re-election; board reduces to eight
Eric K. Brandt will not stand for re-election at the 2025 annual meeting.
Macerich posts Q4 net loss of $211.2M, FFO per share down; executes $454M equity offering
Q4 2024 net loss of $211.2M ($0.89 diluted) vs net income of $62.2M ($0.29) in Q4 2023.
Macerich appoints Devin Murphy, former PECO President, to Board effective Feb 1, 2025
Devin Murphy appointed to Macerich Board effective February 1, 2025; Board expands to nine members.
Macerich closes ~$439M net equity offering to repay $478M Washington Square mortgage
Issued 23M shares plus fully exercised 3M over-allotment at $19.75 per share.
Macerich launches $500M at-the-market equity offering to repay debt
New ATM program allows sale of up to $500M of common stock through multiple agents (JPM, Deutsche, Goldman, BMO, TD).
Macerich Q3 net loss narrows to $108M; FFO $0.38/sh, same-center NOI +1.9%
Q3 net loss $108.2M ($0.50/sh) vs $262.5M loss ($1.22/sh) in Q3 2023.
Macerich appoints Daniel Swanstrom as CFO; Scott Kingsmore to depart Dec 31, 2024
Dan Swanstrom appointed CFO effective Nov 16, 2024; base salary $600K, target bonus 125% of salary, sign-on LTIP grant $1.5M vesting over 3 years.
Macerich posts Q2 net income $252M vs loss year ago; defaults on $300M loan, withdraws guidance
Net income of $252M ($1.16 diluted EPS) vs net loss of $15M in Q2 2023; core FFO per share $0.39 vs $0.40.
Macerich elects former director Diana M. Laing to Board, expanding to 8 members
Diana M. Laing appointed to Macerich Board effective July 18, 2024; Board expands from 7 to 8 members.
Macerich stockholders approve 500,000-share increase in ESPP reserve
ESPP share maximum raised from 1,291,117 to 1,791,117 shares, effective May 30, 2024.
Macerich Q1 net loss widens to $126.7M; withdraws 2024 guidance; defaults on $300M loan
Net loss attributable to Macerich was $126.7M ($0.59 diluted loss per share) in Q1 2024 vs $58.7M loss ($0.27) in Q1 2023.
Macerich director Peggy Alford will not stand for re-election at 2024 annual meeting
Peggy Alford informed Board she will not stand for re-election to focus on other commitments.
Macerich appoints Jackson Hsieh as CEO/President, adds him to Board effective March 1, 2024
Board size increased from 9 to 10 to create vacancy for new director.
Macerich Q4 net income jumps to $62.2M from $1.7M; record leasing, occupancy 93.5%
Net income $62.2M ($0.29 diluted) vs $1.7M ($0.01) in Q4 2022; FFO $0.56/share vs $0.53
Macerich names Jackson Hsieh CEO; O'Hern, Coppola retire Feb 29
Jackson Hsieh appointed CEO and President effective March 1, 2024; succeeds Tom O'Hern (30 yrs) and Ed Coppola (46 yrs).
Director Steven Soboroff to retire from Macerich Board on Dec 31, 2023
Steven Soboroff provided notice of retirement from the Board on December 2, 2023, effective December 31, 2023.
Macerich Q3 net loss $262.5M on $252M impairments; same-center NOI +4.8%
Net loss $262.5M ($1.22 diluted) vs $15.2M loss a year ago; driven by $107.7M impairment on Country Club Plaza and $144.7M on Fashion Outlets of Niagara.
Macerich replaces existing credit facility with $650M revolver maturing 2027, draws $152M
New $650M revolving loan facility matures Feb 1, 2027, with option to extend to Feb 1, 2028.
Macerich Q2 net loss $15M; same center NOI up 5.6%; FFO $0.40/share, guidance narrowed
Q2 net loss $15M ($0.07/diluted) vs $15.4M loss; FFO ex-Chandler Freehold $88.7M ($0.40) down from $102.9M ($0.46).
Macerich files new shelf registration, continues $500M ATM program with agent change
Filed new automatic shelf registration to replace expiring August 2020 S-3.
Stockholders approved the amended 2003 Equity Incentive Plan with 155.2M for, 5.6M against, 284K abstentions.
Macerich Q1 2023 net loss widens to $58.7M; same-center NOI up 4.8% ex lease term
Net loss attributable to company $58.7M ($0.27/diluted) vs loss $37.2M ($0.17/diluted) in Q1 2022.
Macerich Q4 2022: FFO $0.53, same-center NOI +2.0%, occupancy 92.6%
Net income $1.7M ($0.01 diluted EPS) vs net loss $17.1M in Q4 2021.
Macerich amends bylaws to adopt universal proxy rules and enhance stockholder meeting procedures
Board amended and restated Bylaws on Jan 26, 2023 to comply with SEC Rule 14a-19 universal proxy requirements.
Macerich Q3 net loss of $15.2M; FFO $0.46 per share; dividend raised 13.3% to $0.17
Net loss attributable to company $15.2M ($0.07 diluted) vs net income $106.7M ($0.50) in Q3 2021.
Macerich director Diana Laing to retire on Dec 31, 2022; board to shrink by one
Diana Laing notified the board of her retirement, effective December 31, 2022.
Macerich Q2 net loss $15.4M; FFO $0.46; same-center NOI +5.4%; occupancy 91.8%
Net loss $15.4M ($0.07 diluted) vs $11.8M loss in Q2 2021; FFO ex Chandler $102.9M ($0.46) vs $127.6M ($0.59).
Macerich stockholders elect all 12 directors, approve executive compensation, ratify KPMG
All 12 director nominees elected with majority support; Eric Brandt and Diana Laing each received ~14.3M against votes.
Macerich reports Q1 2022: net loss narrows to $37.2M, FFO per share $0.50, occupancy 91.3%
Net loss $37.2M ($0.17/diluted share) vs $63.6M loss ($0.40) in Q1 2021.
Macerich Q4 net loss narrows to $0.08 per share; same-center NOI up 36.1%
Net loss attributable to Macerich was $17.1M ($0.08/diluted share) vs. $190.4M loss ($1.27) in Q4 2020.
On March 12, 2025, Eric K. Brandt advised the Board of Directors (the “Board”) of The Macerich Company (the “Company”) that he will not stand for re-election as a director of the Company at the 2025 annual meeting of stockholders (the “2025 Annual Meeting”).
elected Mr. Devin I. Murphy to the Board effective February 1, 2025.
Scott W. Kingsmore, the Company’s current Senior Executive Vice President, Chief Financial Officer and Treasurer, will be departing the Company effective as of December 31, 2024.
Daniel E. Swanstrom II will be appointed to the role of Senior Executive Vice President, Chief Financial Officer and Treasurer, effective as of November 16, 2024.
the Board of Directors (the “Board”) of The Macerich Company (the “Company”), upon the recommendation of its Nominating and Corporate Governance Committee (the “Committee”), elected Ms. Diana M. Laing to the Board.
On March 20, 2024, Peggy Alford advised the Board of Directors (the “Board”) of The Macerich Company (the “Company”) that she will not stand for re-election as a director of the Company at the 2024 annual meeting of stockholders (the “2024 Annual Meeting”) in order to focus on other commitments.
unanimously appointed Jackson Hsieh to fill the newly created vacancy, effective concurrently with his appointment to the role of Chief Executive Officer and President on March 1, 2024.
unanimously appointed Jackson Hsieh to fill the newly created vacancy, effective concurrently with his appointment to the role of Chief Executive Officer and President on March 1, 2024.
Edward C. Coppola, the Company’s current President, will also be retiring effective as of February 29, 2024
Thomas E. O’Hern, the Company’s current Chief Executive Officer, will be retiring effective as of February 29, 2024
On February 5, 2024, The Macerich Company (the “Company”) announced that Jackson Hsieh will be appointed to the role of Chief Executive Officer and President, effective as of March 1, 2024.
On December 2, 2023, Mr. Steven Soboroff provided notice of his retirement from the Board of Directors (the “Board”) of The Macerich Company (the “Company”) effective December 31, 2023.
Max materiality 0.90 · Median 0.60 · Most common event earnings